A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma

Gemici A., Bilgen H., Erdogan C., Kansu A., Olmuscelik O., Bekoz H. S., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.8, pp.1781-1785, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 8
  • Publication Date: 2020
  • Doi Number: 10.3906/sag-2009-77
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1781-1785
  • Keywords: Convalescent plasma, COVID-19, viral infections
  • Dokuz Eylül University Affiliated: No

Abstract

Background/aim: A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Health authority in Turkey has published a guideline to integrate this promising option in the treatment process of patients who are prone to high risk of developing severe COVID-19.